The US allergic rhinitis market is supported by the widespread burden of seasonal and perennial allergies and continued demand for effective symptom-management therapies. Increasing use of intranasal corticosteroids, antihistamines, and other treatment options, alongside greater awareness and access to allergy care, is creating sustained opportunities for market growth. The allergic rhinitis...